CRISPR Therapeutics AG ($CRSP)
KASINGER JAMES R. โ General Counsel and Secretary
Shares
3,825
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 10, 2026
EPS:Est: -1.15
Feb 12, 2026
EPS:-1.37 (est: -1.16)+17.8%
Revenue:$864.00K (est: $4.72M)-81.7%
Transaction Details
| Insider | KASINGER JAMES R. |
|---|---|
| Title | General Counsel and Secretary |
| Transaction Date | Feb 18, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Shares |
| Direct/Indirect | Direct |
| Filing Date | Feb 20, 2026 |
| Shares Purchased | 3,825 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 87,227 |
| Derivative | No |
| Accession Number | 0001193125-26-061710 |
| Document | View SEC Filing |